arrow
S

Shane Shapera

University of Saskatchewan
H指数:23
被引数:2,719

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of gastroesophageal reflux and proton pump inhibitors in fibrotic interstitial lung disease

胃食管反流和质子泵抑制剂对纤维化间质性肺疾病的影响

2026-05-010
OA
The Clinical Frailty Scale for Risk Stratification fi cation in Patients With Fibrotic Interstitial Lung Disease

纤维化间质性肺疾病患者危险分层的临床虚弱量表

CHEST
IF8.6
2024-09-010
OAAI
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohort

多中心注册队列中手术肺活检对特发性肺纤维化患者肺功能和生存率的影响

2024-03-041
OAAI
Characteristics and risk factors of interstitial pneumonia with autoimmune features
2024-01-011
PRE
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease
2023-12-013
PRE
Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis

特发性肺纤维化和纤维化过敏性肺炎临床实践指南放射学模式的整合和应用

CHEST
IF8.6
2023-12-0110
PRE
The clinical frailty scale is associated with progression of fibrotic interstitial lung disease - a multicentre cohort study.
2023-10-271
PRE
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
2022-05-0518
OAAI
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease

BMI和体重变化与纤维化间质性肺疾病患者死亡率的关系

CHEST
IF8.6
2022-05-0136
PRE
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
2022-03-1085
OA
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study
2022-01-015
OAAI